MedPath

Phase II trial of S-1 based therapy+/-Trastuzmab combination therapy for unresectable gastric cancer

Phase 2
Recruiting
Conditions
unresectable gastric cancer
Registration Number
JPRN-UMIN000006058
Lead Sponsor
2nd department of internal medicine Tottori University school of medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

We exclude all patient who are not eligible for the inclusion

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath